KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Pension (2009 - 2019)

Bristol Myers Squibb (BMY) reported Pension of $2.9 billion for Q4 2019, down 50.72% year-over-year from $6.0 billion in Q4 2018, and down 50.72% on a QoQ basis from $6.0 billion in Q4 2018.

Bristol Myers Squibb (BMY) has 9 years of Pension data on file, last reported at $2.9 billion in Q4 2019.

  • Quarterly Pension fell 50.72% year-over-year to $2.9 billion in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $2.9 billion (down 50.72% YoY) and the FY2019 annual result came in at $2.9 billion, down 50.72% from the prior year.
  • Pension slipped to $2.9 billion in Q4 2019 per BMY's latest filing, from $6.0 billion in the prior quarter.
  • Across five years, Pension topped out at $6.0 billion in Q4 2018 and bottomed at $727.0 million in Q2 2015.
  • The 3-year median for Pension is $1.1 billion (2015), against an average of $2.1 billion.
  • The widest annual swing landed in 2015, when Pension surged 67.54%; it then plunged 50.72% in 2019.
  • Tracing BMY's Pension over 3 years: stood at $949.0 million in 2015, then surged by 528.66% to $6.0 billion in 2018, then sank by 50.72% to $2.9 billion in 2019.
  • Per Business Quant, the three latest BMY Pension figures stand at $2.9 billion (Q4 2019), $6.0 billion (Q4 2018), and $949.0 million (Q4 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2019 2.94 Bn
Dec 31, 2018 5.97 Bn
Dec 31, 2015 949.00 Mn
Sep 30, 2015 902.00 Mn
Jun 30, 2015 727.00 Mn
Mar 31, 2015 1.16 Bn
Dec 31, 2014 1.12 Bn
Sep 30, 2014 806.00 Mn
Jun 30, 2014 681.00 Mn
Mar 31, 2014 690.00 Mn
Dec 31, 2013 718.00 Mn
Sep 30, 2013 773.00 Mn
Jun 30, 2013 826.00 Mn
Mar 31, 2013 1.64 Bn
Dec 31, 2012 1.88 Bn
Sep 30, 2012 1.47 Bn
Jun 30, 2012 1.54 Bn
Mar 31, 2012 1.62 Bn
Dec 31, 2011 2.02 Bn
Sep 30, 2011 811.00 Mn
Jun 30, 2011 870.00 Mn
Mar 31, 2011 922.00 Mn
Dec 31, 2010 1.30 Bn
Dec 31, 2009 1.66 Bn
Sep 30, 2009 1.02 Bn
Jun 30, 2009 1.06 Bn